Clinical Trials Directory

Trials / Completed

CompletedNCT06380062

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Pre-operative Plasma Concentrations of Choline and Its Metabolites in People With Prostate Cancer Compared to Those With Benign Hyperplasia

Status
Completed
Phase
Study type
Observational
Enrollment
350 (actual)
Sponsor
Universität des Saarlandes · Academic / Other
Sex
Male
Age
50 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to investigate plasma concentrations of one-carbon metabolites and phospholipid classes in participants with primary prostate cancer and those with benign hyperplasia. Moreover, the metabolites were studied in relation to tumor grade and age.

Detailed description

This observational study recruited participants with primary prostate cancer (cases) and those with benign hyperplasia (controls) before the surgery. Data on the outcomes of the surgery including the results of the biopsy investigation were collected. Blood samples were collected before the surgery in context of routine blood investigations. Blood plasma samples collected on ethylenediaminetetraacetic acid (EDTA) were used to measure concentrations of free choline, betaine, dimethylglycine, folate forms, S-adenosylhomocysteine, S-adenosylmethionine, homocysteine, cystathionine, and methylmalonic acid (MMA). Data on serum concentrations of prostate specific antigen (PSA) and the tumor grade and classification (Gleason Score system) were collected. The associations between the plasma concentrations of the metabolites and PSA or the Gleason score were studied. The concentrations of the metabolic markers were compared between the cases and the controls according to the age of the participants.

Conditions

Interventions

TypeNameDescription
OTHERPlasma concentration of cholineThe exposure in this observational study is plasma concentrations of choline

Timeline

Start date
2012-01-12
Primary completion
2015-11-30
Completion
2015-11-30
First posted
2024-04-23
Last updated
2024-04-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06380062. Inclusion in this directory is not an endorsement.